Generic competition and prices for azelastine‐fluticasone nasal spray
The original manufacturer of azelastine‒fluticasone (AZ‒FL) prevented generic availability until 2020 via patent enforcement. Following generic availability of AZ‒FL, Medicare utilization increased and spending decreased. Retail prices for generic AZ‒FL remain high due to markup by manufacturers and pharmacies.
Authors
- Vinay K. Rathi (ORCID: https://orcid.org/0000-0002-9763-9075)
- Alan D. Workman (ORCID: https://orcid.org/0000-0001-9573-6472)
- George A. Scangas (ORCID: https://orcid.org/0000-0002-6687-788X)
- Akash M. Bhat (ORCID: https://orcid.org/0000-0003-3744-3174)
- Rodney J. Schlosser (ORCID: https://orcid.org/0000-0001-6480-0275)
- Zachary M. Soler (ORCID: https://orcid.org/0000-0002-4304-595X)
Institutions
- Massachusetts Eye and Ear Infirmary (US)
- Medical University of South Carolina (US)
- Ralph H. Johnson VA Medical Center (US)
- The Ohio State University (US)
- Drexel University (US)
Publication Details
- Journal
- International Forum of Allergy & Rhinology
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1002/alr.23443
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00